JPH11199425A - Cosmetic - Google Patents
CosmeticInfo
- Publication number
- JPH11199425A JPH11199425A JP10000192A JP19298A JPH11199425A JP H11199425 A JPH11199425 A JP H11199425A JP 10000192 A JP10000192 A JP 10000192A JP 19298 A JP19298 A JP 19298A JP H11199425 A JPH11199425 A JP H11199425A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- skin
- cosmetic
- component
- ascorbic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 31
- 150000000996 L-ascorbic acids Chemical class 0.000 claims abstract description 14
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 5
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 claims abstract description 5
- -1 ethyl ascorbic acid Chemical compound 0.000 claims description 24
- 239000006097 ultraviolet radiation absorber Substances 0.000 claims description 12
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 claims description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 7
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 3
- 235000010323 ascorbic acid Nutrition 0.000 claims description 2
- 239000011668 ascorbic acid Substances 0.000 claims description 2
- 229960005070 ascorbic acid Drugs 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 abstract description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 13
- 230000000694 effects Effects 0.000 abstract description 11
- 229940120145 3-o-ethylascorbic acid Drugs 0.000 abstract description 10
- 239000003795 chemical substances by application Substances 0.000 abstract description 6
- 239000002304 perfume Substances 0.000 abstract description 4
- 150000005846 sugar alcohols Polymers 0.000 abstract description 4
- 241001465754 Metazoa Species 0.000 abstract description 3
- 239000002250 absorbent Substances 0.000 abstract description 3
- 230000002745 absorbent Effects 0.000 abstract description 3
- 239000002738 chelating agent Substances 0.000 abstract description 3
- 239000003995 emulsifying agent Substances 0.000 abstract description 3
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract description 3
- 239000003002 pH adjusting agent Substances 0.000 abstract description 3
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 abstract description 2
- 239000000419 plant extract Substances 0.000 abstract description 2
- 239000003381 stabilizer Substances 0.000 abstract description 2
- 239000004094 surface-active agent Substances 0.000 abstract description 2
- 239000002562 thickening agent Substances 0.000 abstract description 2
- 230000003064 anti-oxidating effect Effects 0.000 abstract 1
- 238000004061 bleaching Methods 0.000 abstract 1
- 230000003020 moisturizing effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 28
- 230000002087 whitening effect Effects 0.000 description 12
- 239000000194 fatty acid Substances 0.000 description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- 235000014113 dietary fatty acids Nutrition 0.000 description 10
- 229930195729 fatty acid Natural products 0.000 description 10
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 8
- 239000006096 absorbing agent Substances 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 7
- 229960005150 glycerol Drugs 0.000 description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 239000003963 antioxidant agent Substances 0.000 description 6
- 230000003078 antioxidant effect Effects 0.000 description 6
- 235000006708 antioxidants Nutrition 0.000 description 6
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 235000019441 ethanol Nutrition 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 6
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 239000007844 bleaching agent Substances 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- DSSYKIVIOFKYAU-OIBJUYFYSA-N (S)-camphor Chemical compound C1C[C@]2(C)C(=O)C[C@H]1C2(C)C DSSYKIVIOFKYAU-OIBJUYFYSA-N 0.000 description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 description 4
- 206010014970 Ephelides Diseases 0.000 description 4
- 208000003351 Melanosis Diseases 0.000 description 4
- 206010040880 Skin irritation Diseases 0.000 description 4
- 230000006750 UV protection Effects 0.000 description 4
- 230000002421 anti-septic effect Effects 0.000 description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 230000007794 irritation Effects 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- ZQBAKBUEJOMQEX-UHFFFAOYSA-N phenyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 ZQBAKBUEJOMQEX-UHFFFAOYSA-N 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 230000002335 preservative effect Effects 0.000 description 4
- 231100000475 skin irritation Toxicity 0.000 description 4
- 230000036556 skin irritation Effects 0.000 description 4
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 3
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 3
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 3
- 239000005711 Benzoic acid Substances 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 229960000271 arbutin Drugs 0.000 description 3
- 235000013871 bee wax Nutrition 0.000 description 3
- 239000012166 beeswax Substances 0.000 description 3
- 229940092738 beeswax Drugs 0.000 description 3
- 235000010233 benzoic acid Nutrition 0.000 description 3
- CMDKPGRTAQVGFQ-RMKNXTFCSA-N cinoxate Chemical compound CCOCCOC(=O)\C=C\C1=CC=C(OC)C=C1 CMDKPGRTAQVGFQ-RMKNXTFCSA-N 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000003906 humectant Substances 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- 235000013772 propylene glycol Nutrition 0.000 description 3
- 229960004063 propylene glycol Drugs 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 229960004889 salicylic acid Drugs 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 2
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N Benzyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 description 2
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 206010042496 Sunburn Diseases 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 2
- 239000012965 benzophenone Substances 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000013985 cinnamic acid Nutrition 0.000 description 2
- 229930016911 cinnamic acid Natural products 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- MTZQAGJQAFMTAQ-UHFFFAOYSA-N ethyl benzoate Chemical compound CCOC(=O)C1=CC=CC=C1 MTZQAGJQAFMTAQ-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- LBQIJVLKGVZRIW-UHFFFAOYSA-N glabridine Natural products C1OC2=C3C=CC(C)(C)OC3=CC=C2CC1C1=CC=C(O)C=C1O LBQIJVLKGVZRIW-UHFFFAOYSA-N 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 2
- 229960004705 kojic acid Drugs 0.000 description 2
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 2
- 230000008099 melanin synthesis Effects 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- QUAMTGJKVDWJEQ-UHFFFAOYSA-N octabenzone Chemical compound OC1=CC(OCCCCCCCC)=CC=C1C(=O)C1=CC=CC=C1 QUAMTGJKVDWJEQ-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- PXQPEWDEAKTCGB-UHFFFAOYSA-N orotic acid Chemical compound OC(=O)C1=CC(=O)NC(=O)N1 PXQPEWDEAKTCGB-UHFFFAOYSA-N 0.000 description 2
- 229960000969 phenyl salicylate Drugs 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 239000001593 sorbitan monooleate Substances 0.000 description 2
- 235000011069 sorbitan monooleate Nutrition 0.000 description 2
- 229940035049 sorbitan monooleate Drugs 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- NDVRKEKNSBMTAX-BTVCFUMJSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O NDVRKEKNSBMTAX-BTVCFUMJSA-N 0.000 description 1
- AFDXODALSZRGIH-QPJJXVBHSA-N (E)-3-(4-methoxyphenyl)prop-2-enoic acid Chemical compound COC1=CC=C(\C=C\C(O)=O)C=C1 AFDXODALSZRGIH-QPJJXVBHSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 description 1
- LRZBIPQJHILPJI-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-(2,3-dihydroxypropyl)octadecanoate Chemical compound CCCCCCCCCCCCCCCCC(CC(O)CO)C(=O)OCC(O)CO LRZBIPQJHILPJI-UHFFFAOYSA-N 0.000 description 1
- AFDLXJOBOCFHAE-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-ethylhexanoate 3-(4-methoxyphenyl)prop-2-enoic acid Chemical compound COC1=CC=C(C=CC(O)=O)C=C1.COC1=CC=C(C=CC(O)=O)C=C1.CCCCC(CC)C(=O)OCC(O)CO AFDLXJOBOCFHAE-UHFFFAOYSA-N 0.000 description 1
- WHQOKFZWSDOTQP-UHFFFAOYSA-N 2,3-dihydroxypropyl 4-aminobenzoate Chemical compound NC1=CC=C(C(=O)OCC(O)CO)C=C1 WHQOKFZWSDOTQP-UHFFFAOYSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- IYAZLDLPUNDVAG-UHFFFAOYSA-N 2-(benzotriazol-2-yl)-4-(2,4,4-trimethylpentan-2-yl)phenol Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 IYAZLDLPUNDVAG-UHFFFAOYSA-N 0.000 description 1
- TXBCBTDQIULDIA-UHFFFAOYSA-N 2-[[3-hydroxy-2,2-bis(hydroxymethyl)propoxy]methyl]-2-(hydroxymethyl)propane-1,3-diol Chemical compound OCC(CO)(CO)COCC(CO)(CO)CO TXBCBTDQIULDIA-UHFFFAOYSA-N 0.000 description 1
- ZCOLQXXFCPFSNU-UHFFFAOYSA-N 2-[methyl(tetradecanoyl)amino]ethanesulfonic acid;sodium Chemical compound [Na].CCCCCCCCCCCCCC(=O)N(C)CCS(O)(=O)=O ZCOLQXXFCPFSNU-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- JOKBLKCZHGIRNO-UHFFFAOYSA-N 5-benzoyl-2-hydroxybenzoic acid Chemical compound C1=C(O)C(C(=O)O)=CC(C(=O)C=2C=CC=CC=2)=C1 JOKBLKCZHGIRNO-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- RDBLNMQDEWOUIB-UHFFFAOYSA-N 5-methyl-2-phenyl-1,3-benzoxazole Chemical compound N=1C2=CC(C)=CC=C2OC=1C1=CC=CC=C1 RDBLNMQDEWOUIB-UHFFFAOYSA-N 0.000 description 1
- DQWQLEWWOPBQHX-UHFFFAOYSA-N 5-methyl-4-phenyl-2h-benzotriazole Chemical compound CC1=CC=C2NN=NC2=C1C1=CC=CC=C1 DQWQLEWWOPBQHX-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- ATHHXGZTWNVVOU-UHFFFAOYSA-N N-methylformamide Chemical compound CNC=O ATHHXGZTWNVVOU-UHFFFAOYSA-N 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- YDBYJHTYSHBBAU-YFKPBYRVSA-N S-methyl-L-methioninate Chemical compound C[S+](C)CC[C@H](N)C([O-])=O YDBYJHTYSHBBAU-YFKPBYRVSA-N 0.000 description 1
- 108010013296 Sericins Proteins 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-WAXACMCWSA-N alpha-D-glucuronic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-WAXACMCWSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229940064734 aminobenzoate Drugs 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 229940062909 amyl salicylate Drugs 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- WXNRYSGJLQFHBR-UHFFFAOYSA-N bis(2,4-dihydroxyphenyl)methanone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=C(O)C=C1O WXNRYSGJLQFHBR-UHFFFAOYSA-N 0.000 description 1
- SODJJEXAWOSSON-UHFFFAOYSA-N bis(2-hydroxy-4-methoxyphenyl)methanone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(OC)C=C1O SODJJEXAWOSSON-UHFFFAOYSA-N 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 235000010338 boric acid Nutrition 0.000 description 1
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229940082483 carnauba wax Drugs 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 150000001788 chalcone derivatives Chemical class 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229940114081 cinnamate Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- FGEUKKGODAGXOD-FMIVXFBMSA-N cyclohexyl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound C1=CC(OC)=CC=C1\C=C\C(=O)OC1CCCCC1 FGEUKKGODAGXOD-FMIVXFBMSA-N 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 1
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- WODOUQLMOIMKAL-FJSYBICCSA-L disodium;(2s)-2-(octadecanoylamino)pentanedioate Chemical compound [Na+].[Na+].CCCCCCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O WODOUQLMOIMKAL-FJSYBICCSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- YRIUSKIDOIARQF-UHFFFAOYSA-N dodecyl benzenesulfonate Chemical compound CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 YRIUSKIDOIARQF-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 229940071161 dodecylbenzenesulfonate Drugs 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- KCDAMWRCUXGACP-DHZHZOJOSA-N ethyl (e)-2-cyano-3-phenylprop-2-enoate Chemical compound CCOC(=O)C(\C#N)=C\C1=CC=CC=C1 KCDAMWRCUXGACP-DHZHZOJOSA-N 0.000 description 1
- XRLCQRMNGQRGOC-MDZDMXLPSA-N ethyl (e)-3-[2,4-di(propan-2-yl)phenyl]prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CC=C(C(C)C)C=C1C(C)C XRLCQRMNGQRGOC-MDZDMXLPSA-N 0.000 description 1
- NYNCZOLNVTXTTP-UHFFFAOYSA-N ethyl 2-(1,3-dioxoisoindol-2-yl)acetate Chemical compound C1=CC=C2C(=O)N(CC(=O)OCC)C(=O)C2=C1 NYNCZOLNVTXTTP-UHFFFAOYSA-N 0.000 description 1
- XCRHYAQWBYDRGV-UHFFFAOYSA-N ethyl 3-(4-propan-2-ylphenyl)prop-2-enoate Chemical compound CCOC(=O)C=CC1=CC=C(C(C)C)C=C1 XCRHYAQWBYDRGV-UHFFFAOYSA-N 0.000 description 1
- VBMCJTPQBDEGJR-UHFFFAOYSA-N ethyl 4-(dihydroxyamino)-2-propylbenzoate Chemical compound CCCC1=CC(N(O)O)=CC=C1C(=O)OCC VBMCJTPQBDEGJR-UHFFFAOYSA-N 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 229940043351 ethyl-p-hydroxybenzoate Drugs 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 229940005740 hexametaphosphate Drugs 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 235000014304 histidine Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 150000002462 imidazolines Chemical class 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- SJOXEWUZWQYCGL-DVOMOZLQSA-N menthyl salicylate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-DVOMOZLQSA-N 0.000 description 1
- 229960004665 menthyl salicylate Drugs 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- YKWKFUUHPFWRNV-UHFFFAOYSA-N methyl 3-[2,4-di(propan-2-yl)phenyl]prop-2-enoate Chemical compound COC(=O)C=CC1=CC=C(C(C)C)C=C1C(C)C YKWKFUUHPFWRNV-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- MJVGBKJNTFCUJM-UHFFFAOYSA-N mexenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(C)C=C1 MJVGBKJNTFCUJM-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical compound C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- FFZFHRYMHDWKAX-UHFFFAOYSA-N octyl 2-aminobenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1N FFZFHRYMHDWKAX-UHFFFAOYSA-N 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- VIKVSUVYUVJHOA-UHFFFAOYSA-N octyl 3-phenylprop-2-enoate Chemical compound CCCCCCCCOC(=O)C=CC1=CC=CC=C1 VIKVSUVYUVJHOA-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229960005010 orotic acid Drugs 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- FZUGPQWGEGAKET-UHFFFAOYSA-N parbenate Chemical compound CCOC(=O)C1=CC=C(N(C)C)C=C1 FZUGPQWGEGAKET-UHFFFAOYSA-N 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- LYXOWKPVTCPORE-UHFFFAOYSA-N phenyl-(4-phenylphenyl)methanone Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1C(=O)C1=CC=CC=C1 LYXOWKPVTCPORE-UHFFFAOYSA-N 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- WZXKPNYMUZGZIA-RMKNXTFCSA-N propyl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound CCCOC(=O)\C=C\C1=CC=C(OC)C=C1 WZXKPNYMUZGZIA-RMKNXTFCSA-N 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- SJOXEWUZWQYCGL-UHFFFAOYSA-N salicylic acid menthyl ester Natural products CC(C)C1CCC(C)CC1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-UHFFFAOYSA-N 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は化粧料に関し、さら
に詳しくは、皮膚に対して優れた紫外線防御効果と美白
効果を有し、かつ皮膚安全性に優れるとともに、保存安
定性の良好な皮膚用化粧料に関するものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a cosmetic, and more particularly, to a cosmetic for skin having an excellent UV protection effect and a whitening effect on the skin, excellent skin safety and good storage stability. It concerns cosmetics.
【0002】[0002]
【従来の技術】紫外線(UV)は、波長400〜320
nmのUVAと波長320〜290nmのUVBと波長
290〜180nmのUVCとに分けられる。これらの
うち、UVCは、大気圏上層にあるオゾン層で吸収散乱
されるなどして地表には到達しない。地表に到達する紫
外線UVAとUVBが人体に直接強い影響を与える。2. Description of the Related Art Ultraviolet light (UV) has a wavelength of 400 to 320.
nmA, UVB having a wavelength of 320 to 290 nm, and UVC having a wavelength of 290 to 180 nm. Of these, UVC does not reach the surface of the earth because it is absorbed and scattered by the ozone layer in the upper atmosphere. Ultraviolet rays UVA and UVB reaching the ground surface have a strong direct effect on the human body.
【0003】UVAは、もっているエネルギーそのもの
は弱いものの、肌の奥の真皮まで届き、肌の老化を促進
する。一方、UVBは強いエネルギーをもっており、肌
の表面で炎症を起こし肌をかさつかせる。[0003] Although UVA has weak energy itself, it reaches the dermis deep in the skin and promotes aging of the skin. On the other hand, UVB has strong energy and causes inflammation on the surface of the skin to make the skin bulk.
【0004】ところで、皮膚の黒化には、色素のメラニ
ンが深く関与しているものと考えられる。すなわち、紫
外線などの外的刺激を受け、肌の皮膚組織でメランが生
産され、その結果、肌の黒化が促進され、シミやソバカ
ス、色黒などの症状が引き起こされるものと考えられ
る。したがって、紫外線を防御するため、これまで様々
な紫外線吸収剤が使用されてきた。しかしながら、紫外
線吸収剤は、一般に少量では防御効果が弱く、また防御
効果を高めるために多量に使用すると皮膚刺激などが生
じるという問題があった。[0004] It is considered that pigment melanin is deeply involved in skin darkening. In other words, it is considered that melan is produced in the skin tissue of the skin upon receiving an external stimulus such as ultraviolet rays, and as a result, the blackening of the skin is promoted, and symptoms such as spots, freckles, and darkness are caused. Therefore, various UV absorbers have been used to protect against UV rays. However, the UV absorber generally has a problem that the protective effect is weak when the UV absorber is used in a small amount, and skin irritation occurs when the UV absorber is used in a large amount to enhance the protective effect.
【0005】一方、近年、皮膚科学の進歩に伴い、複雑
なメラニン生成メカニズムが解明されて以来、過剰なメ
ラニンの生成を抑制する美白剤の開発が進められ、すで
に実用化しているものもある。このような美白剤として
は、例えばビタミンC及びその誘導体、アルブチン、コ
ウジ酸、グラブリジンなどがある。しかしながら、これ
らの美白剤は、保存安定性が悪かったり、美白効果が十
分でなかったり、あるいは入手しにくく、高価であるな
ど、必ずしも十分に満足しうるものではなかった。On the other hand, in recent years, with the advancement of dermatology and the elucidation of the complex mechanism of melanin production, the development of whitening agents for suppressing excessive melanin production has been promoted, and some of them have already been put to practical use. Such whitening agents include, for example, vitamin C and its derivatives, arbutin, kojic acid, glabridine and the like. However, these whitening agents are not always satisfactory, such as poor storage stability, insufficient whitening effect, or are difficult to obtain and expensive.
【0006】[0006]
【発明が解決しようとする課題】本発明は、このような
事情のもとで、皮膚に対して優れた紫外線防御効果と美
白効果を有し、かつ皮膚安全性に優れるとともに、保存
安定性が良好で、しかも経済的に有利な皮膚用化粧料を
提供することを目的とするものである。Under such circumstances, the present invention has an excellent ultraviolet protection effect and a whitening effect on the skin, and has excellent skin safety and storage stability. An object of the present invention is to provide a good and economically advantageous skin cosmetic.
【0007】[0007]
【課題を解決するための手段】本発明者らは、前記の好
ましい性質を有する皮膚用化粧料を開発すべく鋭意研究
を重ねた結果、L−アスコルビン酸誘導体と紫外線吸収
剤とを併用することで、相乗効果により、その目的を達
成しうることを見出し、この知見に基づいて本発明を完
成するに至った。Means for Solving the Problems The present inventors have made intensive studies to develop a skin cosmetic having the above-mentioned preferable properties, and as a result, have found that an L-ascorbic acid derivative and an ultraviolet absorber are used in combination. Thus, they have found that the object can be achieved by a synergistic effect, and have completed the present invention based on this finding.
【0008】すなわち、本発明は、(A)一般式(I)That is, the present invention relates to (A) a compound represented by the general formula (I)
【化2】 (式中、Rは炭素数1〜22のアルキル基である。)で
表されるL−アスコルビン酸誘導体と、(B)紫外線吸
収剤を含有することを特徴とする化粧料を提供するもの
である。Embedded image (Wherein, R is an alkyl group having 1 to 22 carbon atoms), and a cosmetic comprising (B) an ultraviolet absorber and an L-ascorbic acid derivative. is there.
【0009】[0009]
【発明の実施の形態】本発明の化粧料においては、
(A)成分として、一般式(I)BEST MODE FOR CARRYING OUT THE INVENTION In the cosmetic of the present invention,
As the component (A), general formula (I)
【化3】 (式中、Rは炭素数1〜22のアルキル基である。)で
表されるL−アスコルビン酸誘導体が用いられる。Embedded image (In the formula, R is an alkyl group having 1 to 22 carbon atoms.) An L-ascorbic acid derivative represented by the following formula is used.
【0010】上記一般式(I)におけるRで示される炭
素数1〜22のアルキル基は直鎖状、分岐状、環状のい
ずれであってもよく、その例としてはメチル基、エチル
基、n−プロピル基、イソプロピル基、n−ブチル基、
イソブチル基、sec−ブチル基、tert−ブチル
基、ペンチル基、ヘキシル基、オクチル基、デシル基、
ドデシル基、テトラデシル基、ヘキサデシル基、オクタ
デシル基、ベヘニル基、シクロプロピル基、シクロブチ
ル基、シクロペンチル基、シクロヘキシル基、シクロオ
クチル基などが挙げられる。The alkyl group having 1 to 22 carbon atoms represented by R in the general formula (I) may be linear, branched or cyclic, such as methyl, ethyl, n -Propyl group, isopropyl group, n-butyl group,
Isobutyl group, sec-butyl group, tert-butyl group, pentyl group, hexyl group, octyl group, decyl group,
Dodecyl group, tetradecyl group, hexadecyl group, octadecyl group, behenyl group, cyclopropyl group, cyclobutyl group, cyclopentyl group, cyclohexyl group, cyclooctyl group and the like.
【0011】この一般式(I)で表されるL−アスコル
ビン酸誘導体は公知の化合物であって、例えば特開平8
−134055号公報記載の方法などに従って容易に製
造することができる。The L-ascorbic acid derivative represented by the general formula (I) is a known compound.
It can be easily produced according to the method described in JP-A-134055.
【0012】本発明の化粧料においては、(A)成分と
して、前記一般式(I)で表されるL−アスコルビン酸
誘導体を1種用いてもよいし、2種以上組み合わせて用
いてもよいが、特に、効果おび安定性などの点から、R
がエチル基であるL−3−O−エチルアスコルビン酸が
好適である。In the cosmetic of the present invention, as the component (A), one kind of the L-ascorbic acid derivative represented by the above general formula (I) may be used, or two or more kinds may be used in combination. However, from the viewpoint of effect and stability,
Is an ethyl group, and L-3-O-ethylascorbic acid is preferred.
【0013】本発明の化粧料においては、(B)成分と
して紫外線吸収剤が用いられる。この紫外線吸収剤は、
例えば安息香酸系、サリチル酸系、桂皮酸系、ベンゾフ
ェノン系、その他に分類することができる。In the cosmetic of the present invention, an ultraviolet absorber is used as the component (B). This UV absorber
For example, it can be classified into benzoic acid, salicylic acid, cinnamic acid, benzophenone, and others.
【0014】安息香酸系紫外線吸収剤としては、例えば
p−アミノ安息香酸、p−アミノ安息香酸グリセリルエ
ステル、N,N−ジヒドロキシプロピル−p−アミノ安
息香酸エチルエステル、N−エトキシレート−p−アミ
ノ安息香酸エチルエステル、N,N−ジメチル−p−ア
ミノ安息香酸エチルエステル、N,N−ジメチル−p−
アミノ安息香酸アミルエステル、N,N−ジメチル−p
−アミノ安息香酸オクチルエステル、N−アセチル−o
−アミノ安息香酸ホモメンチルエステルなどが挙げられ
る。Examples of the benzoic acid ultraviolet absorber include p-aminobenzoic acid, glyceryl p-aminobenzoate, ethyl N, N-dihydroxypropyl-p-aminobenzoate, and N-ethoxylate-p-amino. Benzoic acid ethyl ester, N, N-dimethyl-p-aminobenzoic acid ethyl ester, N, N-dimethyl-p-
Amylaminobenzoic acid ester, N, N-dimethyl-p
Octyl aminobenzoate, N-acetyl-o
-Homobenzoyl aminobenzoate, and the like.
【0015】サリチル酸系紫外線吸収剤としては、例え
ばアミルサリシレート、メンチルサリシレート、オクチ
ルサリシレート、フェニルサリシレート、ベンジルサリ
シレート、p−イソプロパノールフェニルサリシレート
などが挙げられる。Examples of the salicylic acid-based ultraviolet absorber include amyl salicylate, menthyl salicylate, octyl salicylate, phenyl salicylate, benzyl salicylate, p-isopropanol phenyl salicylate and the like.
【0016】桂皮酸系紫外線吸収剤としては、例えばオ
クチルシンナメート、エチル4−イソプロピルシンナメ
ート、エチル2,4−ジイソプロピルシンナメート、メ
チル2,4−ジイソプロピルシンナメート、プロピルp
−メトキシシンナメート、イソプロビルp−メトキシシ
ンナメート、オクチルp−メトキシシンナメート、2−
エトキシエチルp−メトキシシンナメート、シクロヘキ
シル−p−メトキシシンナメート、エチルα−シアノ−
β−フェニルシンナメート、2−エチルヘキシルα−シ
アノ−β−フェニルシンナメート、グリセリルモノ(2
−エチルヘキサノエート)−ジ(p−メトキシシンナメ
ート)などが挙げられる。Examples of the cinnamic acid ultraviolet absorber include octyl cinnamate, ethyl 4-isopropyl cinnamate, ethyl 2,4-diisopropyl cinnamate, methyl 2,4-diisopropyl cinnamate, propyl p
-Methoxycinnamate, isoprovir p-methoxycinnamate, octyl p-methoxycinnamate, 2-
Ethoxyethyl p-methoxycinnamate, cyclohexyl-p-methoxycinnamate, ethyl α-cyano-
β-phenylcinnamate, 2-ethylhexyl α-cyano-β-phenylcinnamate, glyceryl mono (2
-Ethylhexanoate) -di (p-methoxycinnamate) and the like.
【0017】ベンゾフェノン系紫外線吸収剤としては、
例えば2,4−ジヒドロキシベンゾフェノン、2,2′
−ジヒドロキシ−4−メトキシベンゾフェノン、2,
2′−ジヒドロキシ−4,4′−ジメトキシベンゾフェ
ノン、2,2′,4,4′−テトラヒドロキシベンゾフ
ェノン、2−ヒドロキシ−4−メトキシベンゾフェノ
ン、2−ヒドロキシ−4−メトキシ−4′−メチルベン
ゾフェノン、4−フェニルベンゾフェノン、2−エチル
ヘキシル4′−フェニルベンゾフェノン−2−カルボキ
シレート、2−ヒドロキシ−4−n−オクトキシベンゾ
フェノン、4−ヒドロキシ−3−カルボキシベンゾフェ
ノンなどが挙げられる。As the benzophenone-based ultraviolet absorber,
For example, 2,4-dihydroxybenzophenone, 2,2 '
-Dihydroxy-4-methoxybenzophenone, 2,
2'-dihydroxy-4,4'-dimethoxybenzophenone, 2,2 ', 4,4'-tetrahydroxybenzophenone, 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone, 4-phenylbenzophenone, 2-ethylhexyl 4'-phenylbenzophenone-2-carboxylate, 2-hydroxy-4-n-octoxybenzophenone, 4-hydroxy-3-carboxybenzophenone and the like.
【0018】その他紫外線吸収剤としては、例えば3−
(4′−メチルベンジリデン)−d,l−カンファー、
3−ベンジリデン−d,l−カンファー、ウロカニン
酸、ウロカニン酸エチルエステル、2−フェニル−5−
メチルベンゾキサゾール、2,2′−ヒドロキシ−5−
メチルフェニルベンゾトリアゾール、2−(2′−ヒド
ロキシ−5−t−オクチルフェニル)ベンゾトリアゾー
ル、ジベンザラジン、ジアニソイルメタン、4−メトキ
シ−4′−t−ブチルジベンゾイルメタン、5−(3,
3−ジメチル−2−ノルボルニリデン)−3−ペンタン
−2−オン、カルコン誘導体などが挙げられるが、もち
ろんこれらに限定されるものではない。Other UV absorbers include, for example, 3-
(4'-methylbenzylidene) -d, l-camphor,
3-benzylidene-d, l-camphor, urocanic acid, urocanic acid ethyl ester, 2-phenyl-5-
Methylbenzoxazole, 2,2'-hydroxy-5
Methylphenylbenzotriazole, 2- (2'-hydroxy-5-t-octylphenyl) benzotriazole, dibenzarazine, dianisoyylmethane, 4-methoxy-4'-t-butyldibenzoylmethane, 5- (3
Examples thereof include, but are not limited to, 3-dimethyl-2-norbornylidene) -3-pentan-2-one and chalcone derivatives.
【0019】これらの紫外線吸収剤は単独で用いてもよ
いし、2種以上を組み合わせて用いてもよいが、より優
れた美白効果と刺激感緩和効果が得られる点から、特に
オクチルp−メトキシシンナメート、2−ヒドロキシ−
4−メトキシベンゾフェノン及び4−メトキシ−4′−
t−ブチル−ジベンゾイルメタンが好適である。These ultraviolet absorbers may be used alone or in combination of two or more. However, octyl p-methoxy is particularly preferred in that a more excellent whitening effect and a stimulating effect can be obtained. Cinnamate, 2-hydroxy-
4-methoxybenzophenone and 4-methoxy-4'-
t-Butyl-dibenzoylmethane is preferred.
【0020】本発明の化粧料においては、前記(A)成
分のL−アスコルビン酸誘導体と(B)成分の紫外線吸
収剤の含有割合は、重量比で1:50〜50:1の範囲
にあることが重要である。この割合が上記範囲を逸脱す
ると相乗効果が充分に発揮されず、本発明の目的が達せ
られない。相乗効果を充分に発揮させ、紫外線防御効
果、美白効果、皮膚に対する安全性及び保存安定性が高
いレベルでバランスした化粧料を得るには、この(A)
成分と(B)成分との割合は、重量比で1:30〜3
0:1の範囲が好ましく、特に1:10〜10:1の範
囲が好適である。In the cosmetic of the present invention, the content ratio of the L-ascorbic acid derivative of the component (A) and the ultraviolet absorbent of the component (B) is in the range of 1:50 to 50: 1 by weight. This is very important. If this ratio deviates from the above range, the synergistic effect is not sufficiently exhibited, and the object of the present invention cannot be achieved. In order to obtain a cosmetic composition which exhibits a synergistic effect sufficiently and has a balanced level of ultraviolet protection effect, whitening effect, skin safety and storage stability at a high level, (A)
The ratio of the component to the component (B) is from 1:30 to 3 by weight.
A range of 0: 1 is preferred, and a range of 1:10 to 10: 1 is particularly preferred.
【0021】本発明の化粧料における前記(A)成分の
L−アスコルビン酸誘導体の含有量は、化粧料の形態に
応じて適宜選定されるが、一般的には、化粧料全量に基
づき、0.01〜10.0重量%の範囲で選ばれる。こ
の量が0.01重量%未満では美白効果が十分に発揮さ
れないおそれがあるし、10.0重量%を超えるとその
量の割には効果の向上が認められず、むしろ経済的に不
利となる。美白効果及び経済性などを考慮すると、この
L−アスコルビン酸誘導体の含有量は、特に0.1〜
5.0重量%の範囲が好ましい。The content of the L-ascorbic acid derivative of the component (A) in the cosmetic of the present invention is appropriately selected according to the form of the cosmetic, but is generally 0 based on the total amount of the cosmetic. It is selected in the range of 0.01 to 10.0% by weight. If the amount is less than 0.01% by weight, the whitening effect may not be sufficiently exerted. If the amount is more than 10.0% by weight, no improvement in the effect can be recognized for the amount. Become. Taking into account the whitening effect and economic efficiency, the content of the L-ascorbic acid derivative is particularly preferably 0.1 to
A range of 5.0% by weight is preferred.
【0022】また、本発明の化粧料における前記(B)
成分の紫外線吸収剤の含有量は、化粧料の形態に応じて
適宜選定されるが、一般的には、化粧料全量に基づき、
0.1〜20.0重量%の範囲で選ばれる。この量が
0.1重量%未満では紫外線防御効果が充分に発揮され
ないおそれがあるし、20.0重量%を超えると皮膚に
対する刺激性が強くなり、好ましくない。紫外線防御効
果及び皮膚に対する刺激性を考慮すると、この紫外線吸
収剤の含有量は、特に1.0〜5.0重量%の範囲が好
ましい。Further, the above-mentioned (B) in the cosmetic of the present invention.
The content of the component ultraviolet absorber is appropriately selected according to the form of the cosmetic, but generally, based on the total amount of the cosmetic,
It is selected in the range of 0.1 to 20.0% by weight. If the amount is less than 0.1% by weight, the effect of protecting against ultraviolet rays may not be sufficiently exerted. If the amount exceeds 20.0% by weight, irritation to the skin is increased, which is not preferable. In consideration of the UV protection effect and the irritation to the skin, the content of the UV absorber is preferably in the range of 1.0 to 5.0% by weight.
【0023】本発明の化粧料には、前記必須成分以外
に、所望に応じ、従来皮膚用化粧料に慣用されている各
種成分、例えば保湿剤、動植物抽出物、多価アルコー
ル、低級アルコール、界面活性剤、乳化剤、乳化安定
剤、防腐防菌剤、香料、増粘剤、酸化防止剤、キレート
剤、pH調整剤、色素、紫外線散乱剤、ビタミン類、ア
ミノ酸類、他の美白剤、抗炎症剤、収斂剤、水などを配
合することができる。In the cosmetic of the present invention, in addition to the above essential components, if desired, various components conventionally used in skin cosmetics, such as humectants, animal and plant extracts, polyhydric alcohols, lower alcohols, Activator, emulsifier, emulsion stabilizer, antiseptic, antiseptic, perfume, thickener, antioxidant, chelating agent, pH adjuster, pigment, ultraviolet scattering agent, vitamins, amino acids, other whitening agents, anti-inflammatory Agents, astringents, water and the like can be added.
【0024】前記保湿剤としては、例えばポリエチレン
グリコールやポリプロピレングリコールなどのポリエー
テル類、グリセリン、1,3−ブチレングリコール、プ
ロピレングリコール、ソルビトールなどの多価アルコー
ル類、さらにはNMF(天然保湿因子)類、具体的には
アミノ酸、尿素、乳酸ナトリウム、ピロリドンカルボン
酸ナトリウムや、ヒアルロン酸、コンドロイチン硫酸な
どのムコ多糖類、コラーゲンやエラスチンなどのタンパ
ク質などが挙げられる。Examples of the humectant include polyethers such as polyethylene glycol and polypropylene glycol, polyhydric alcohols such as glycerin, 1,3-butylene glycol, propylene glycol and sorbitol, and NMF (natural humectant). Specific examples include amino acids, urea, sodium lactate, sodium pyrrolidonecarboxylate, mucopolysaccharides such as hyaluronic acid and chondroitin sulfate, and proteins such as collagen and elastin.
【0025】油分としては、例えばヒマシ油、オリーブ
油、ホホバ油、椿油などの液体油脂、硬化ヒマシ油など
の固体油脂、ラノリン、鯨ロウ、蜜ロウ、カルナウバロ
ウ、キャンデリラロウなどのロウ類、スクワラン、ワセ
リン、流動パラフィン、セリシン、パラフィンなどの炭
化水素類などが挙げられる。Examples of the oil component include liquid oils such as castor oil, olive oil, jojoba oil and camellia oil, solid oils such as hardened castor oil, waxes such as lanolin, whale wax, beeswax, carnauba wax, candelilla wax, squalane, Examples include hydrocarbons such as petrolatum, liquid paraffin, sericin, and paraffin.
【0026】多価アルコールとしては、例えばグリセリ
ン、ポリグリセリン、トリメチロールプロパン、ペンタ
エリスリトール、ジペンタエリスリトール、エチレング
リコール、プロピレングリコール、ポリプロピレングリ
コール、1,3−ブチレングリコール、1,4−ブチレ
ングリコール、さらにはグルコース、マルトース、マン
ノース、ラクトース、D−グルクロン酸、ウロン酸、サ
ッカロース、D−マンニット、D−ソルビット、ソルビ
タン、グルコラクトン、セルロース、デンプン、アルブ
チン、グルコースリン酸エステルなどの単糖類、多糖類
及びこれらの誘導体などが挙げられる。また、低級アル
コールとしては、例えばエチルアルコール、プロピルア
ルコール、イソプロピルアルコールなどが挙げられる。Examples of polyhydric alcohols include glycerin, polyglycerin, trimethylolpropane, pentaerythritol, dipentaerythritol, ethylene glycol, propylene glycol, polypropylene glycol, 1,3-butylene glycol, 1,4-butylene glycol, and the like. Are glucose, maltose, mannose, lactose, D-glucuronic acid, uronic acid, saccharose, D-mannitol, D-sorbitol, sorbitan, glucolactone, cellulose, starch, arbutin, monosaccharides such as glucose phosphate, and polysaccharides And their derivatives. Examples of the lower alcohol include ethyl alcohol, propyl alcohol, and isopropyl alcohol.
【0027】界面活性剤としては、例えばポリオキシエ
チレン(POE)ソルビタンモノオレエートなどのPO
Eソルビタンエステル、ソルビタンモノオレエートなど
のソルビタンエステル、POE−グリセリルモノオレエ
ートなどのPOE−グリセリン脂肪酸エステル、グリセ
リンモノオレエートなどのグリセリン脂肪酸エステル、
POE−モノオレエートなどのPOE−脂肪酸エステ
ル、POE−ラウリルエーテルなどのPOE−アルキル
エーテル、POE−オクチルドデシルエーテルなどのP
OE−分岐アルキルエーテル、POE−ノニルフェニル
エーテルなどのPOE−アルキルフェニルエーテル、グ
リセロールモノイソステアレートなどのグリセロールエ
ステル、POE−グリセロールモノイソステアレートな
どのPOE−グリセロールエステル、ジグリセリルモノ
ステアレートなどのポリグリセリン脂肪酸エステルなど
の非イオン性界面活性剤、ステアリン酸などの高級脂肪
酸のナトリウム塩やカリウム塩などの脂肪酸石ケン、ラ
ウリル硫酸ナトリウムなどの高級アルキル硫酸エステル
塩、POE−ラウリル硫酸トリエタノールアミンなどの
アルキルエーテル硫酸エステル、ラウロイルサルコシン
ナトリウムなどのN−アシルサルコシン酸塩、N−ミリ
ストイル−N−メチルタウリンナトリウムなどの高級脂
肪酸アミドスルホン酸塩、リニアドデシルベンゼンスル
ホン酸ナトリウムなどのアルキルベンゼンスルホン酸ナ
トリウム、N−ステアロイルグルタミン酸ジナトリウム
などのN−アシルグルタミン酸塩などの陰イオン性界面
活性剤、アルキルアミン塩、POE−アルキルアミン
塩、ポリアミン脂肪酸誘導体、アルキルピリジニウム
塩、アルキル四級アンモニウム塩、アルキルジメチルベ
ンジルアンモニウム塩、アルキルイソキノリニウム塩、
ジアルキルモリホニウム塩、塩化ベンゼトニウムなどの
陽イオン性界面活性剤、ベタイン系、イミダゾリン系、
アミンオキシド系などの両性界面活性剤が挙げられる。As the surfactant, for example, polyoxyethylene (POE) sorbitan monooleate or the like
E sorbitan esters, sorbitan esters such as sorbitan monooleate, POE-glycerin fatty acid esters such as POE-glyceryl monooleate, glycerin fatty acid esters such as glycerin monooleate,
POE-fatty acid esters such as POE-monooleate; POE-alkyl ethers such as POE-lauryl ether; PEs such as POE-octyldodecyl ether;
OE-branched alkyl ethers, POE-alkyl phenyl ethers such as POE-nonylphenyl ether, glycerol esters such as glycerol monoisostearate, POE-glycerol esters such as POE-glycerol monoisostearate, diglyceryl monostearate and the like. Nonionic surfactants such as polyglycerin fatty acid esters, fatty acid soaps such as sodium and potassium salts of higher fatty acids such as stearic acid, higher alkyl sulfates such as sodium lauryl sulfate, POE-lauryl sulfate triethanolamine, etc. Alkyl ether sulfates, N-acyl sarcosine salts such as sodium lauroyl sarcosine, and higher fatty acid amide sulfo such as N-myristoyl-N-methyltaurine sodium. Acid salts, anionic surfactants such as sodium alkylbenzenesulfonate such as sodium linear dodecylbenzenesulfonate, N-acyl glutamates such as disodium N-stearoylglutamate, alkylamine salts, POE-alkylamine salts, polyamine fatty acids Derivatives, alkylpyridinium salts, alkyl quaternary ammonium salts, alkyldimethylbenzylammonium salts, alkylisoquinolinium salts,
Cationic surfactants such as dialkyl morphonium salts and benzethonium chloride, betaines, imidazolines,
Examples include amphoteric surfactants such as amine oxides.
【0028】乳化剤としては、例えばグリセリン脂肪酸
エステル、ソルビタン脂肪酸エステル、プロピレングリ
コール脂肪酸エステル、大豆リン脂質などが挙げられ、
香料としては、例えば香精などの植物性天然香料、動物
性天然香料、合成香料などが挙げられる。Examples of the emulsifier include glycerin fatty acid ester, sorbitan fatty acid ester, propylene glycol fatty acid ester, soybean phospholipid and the like.
Examples of the flavor include plant natural flavors such as incense, animal natural flavors, and synthetic flavors.
【0029】防腐防菌剤としては、例えばp−ヒドロキ
シ安息香酸メチル、p−ヒドロキシ安息香酸エチル、デ
ヒドロ酢酸、サリチル酸、安息香酸、ソルビン酸、塩化
ベンザルコニウムなどが挙げられ、増粘剤としては、例
えばアルギン酸ナトリウム、キサンタンガム、ケイ酸ア
ルミニウム、マロメロ種子抽出物、トラガントガム、デ
ンプンなどの天然高分子物質、メチルセルロース、ヒド
ロキシエチルセルロース、カルボキシメチルセルロー
ス、可溶性デンプン、カチオン化セルロースなどの半合
成高分子物質、カルボキシビニルポリマー、ポリビニル
アルコールなどの合成高分子物質などが挙げられる。Examples of the antiseptic / antiseptic include methyl p-hydroxybenzoate, ethyl p-hydroxybenzoate, dehydroacetic acid, salicylic acid, benzoic acid, sorbic acid, benzalkonium chloride and the like. For example, natural polymer substances such as sodium alginate, xanthan gum, aluminum silicate, malomelo seed extract, tragacanth gum, starch, semi-synthetic polymer substances such as methylcellulose, hydroxyethylcellulose, carboxymethylcellulose, soluble starch, cationized cellulose, carboxyvinyl Examples of the polymer include synthetic polymers such as polymers and polyvinyl alcohol.
【0030】また、酸化防止剤としては、例えばジブチ
ルヒドロキシトルエン、ブチルヒドロキシアニソール、
没食子酸プロピル、アスコルビン酸などが、キレート剤
としては、例えばエデト酸二ナトリウム、エタンヒドロ
キシジホスフェート、ピロリン酸塩、ヘキサメタリン酸
塩、クエン酸、酒石酸、グルコン酸などが、pH調整剤
としては、例えば水酸化ナトリウム、トリエタノールア
ミン、クエン酸、クエン酸ナトリウム、ホウ酸、ホウ
砂、リン酸一水素ナトリウムなどが挙げられる。Examples of the antioxidant include dibutylhydroxytoluene, butylhydroxyanisole,
As propyl gallate, ascorbic acid, etc., as chelating agents, for example, disodium edetate, ethanehydroxydiphosphate, pyrophosphate, hexametaphosphate, citric acid, tartaric acid, gluconic acid, etc., as a pH adjuster, Examples include sodium hydroxide, triethanolamine, citric acid, sodium citrate, boric acid, borax, sodium hydrogen phosphate and the like.
【0031】さらに、紫外線散乱剤としては、例えば酸
化チタン、カオリン、タルクなどが、ビタミン類として
は、例えばビタミンA、ビタミンB、ビタミンC、ビタ
ミンD、ビタミンE、ビタミンF、ビタミンK、ビタミ
ンP、ビタミンU、カルニチン、フェルラ酸、α−オリ
ザノール、α−リボ酸、オロット酸及びその誘導体など
が、アミノ酸類としては、例えばグリシン、アラニン、
バリン、ロイシン、イソロイシン、セリン、トレオニ
ン、フェニルアラニン、チロシン、トリプトファン、シ
スチン、システイン、メチオニン、プロリン、ヒドロキ
シプロリン、アスパラギン酸、グルタミン酸、アルギニ
ン、ヒスチジン、リジン及びこれらの誘導体などが挙げ
られる。Further, as the ultraviolet scattering agent, for example, titanium oxide, kaolin, talc, etc., and as the vitamins, for example, vitamin A, vitamin B, vitamin C, vitamin D, vitamin E, vitamin F, vitamin K, vitamin P , Vitamin U, carnitine, ferulic acid, α-oryzanol, α-riboic acid, orotic acid and derivatives thereof, and the like, as amino acids, for example, glycine, alanine,
Examples include valine, leucine, isoleucine, serine, threonine, phenylalanine, tyrosine, tryptophan, cystine, cysteine, methionine, proline, hydroxyproline, aspartic acid, glutamic acid, arginine, histidine, lysine and derivatives thereof.
【0032】他の美白剤としては、例えばアルブチン、
コウジ酸、グラブリジン、プラセンタエキス、エラグ酸
などが挙げられる。Other whitening agents include, for example, arbutin,
Kojic acid, glabridine, placenta extract, ellagic acid and the like can be mentioned.
【0033】本発明の化粧料は、前記(A)成分のL−
アスコルビン酸誘導体、(B)成分の紫外線吸収剤およ
びこれらの任意成分を、公知の方法に従って適当に配合
することにより、化粧水、乳液、クリーム、パック剤、
パウダー、スプレー、軟膏、分散液、洗浄料など、種々
の皮膚用製品形態として用いることができる。The cosmetic of the present invention comprises the component (A) L-
By appropriately blending the ascorbic acid derivative, the ultraviolet absorber of the component (B) and these optional components according to a known method, a lotion, an emulsion, a cream, a pack,
It can be used as various skin product forms such as powder, spray, ointment, dispersion, and cleanser.
【0034】例えば、乳液などの場合、油相および水相
をそれぞれ加熱溶解したものを混合し、乳化分散させて
冷却する通常の方法により調製することができる。For example, in the case of an emulsion or the like, it can be prepared by a usual method in which an oil phase and an aqueous phase, each of which is heated and dissolved, are mixed, emulsified, dispersed and cooled.
【0035】[0035]
【実施例】次に、本発明を実施例により、さらに詳細に
説明するが、本発明は、これらの例によってなんら限定
されるものではない。Next, the present invention will be described in more detail with reference to examples, but the present invention is not limited to these examples.
【0036】 実施例1 化粧水の調製 (重量%) (a) 4−tert−ブチル−4′−メトキシジベンゾイルメタン 0.5 (b) L−3−O−エチルアスコルビン酸 1.0 (c) グリセリン 5.0 (d) ポリオキシエチレンソルビタンモノラウレート(2OE.O.)1.0 (e) エタノール 6.0 (f) 香料 適量 (g) 防腐剤・酸化防止剤 適量 (h) 精製水 残部 合計 100.0 上記(a)〜(h)成分を混合し、均一に溶解することによ
り化粧水を調製した。Example 1 Preparation of lotion (% by weight) (a) 4-tert-butyl-4'-methoxydibenzoylmethane 0.5 (b) L-3-O-ethylascorbic acid 1.0 (c) ) Glycerin 5.0 (d) Polyoxyethylene sorbitan monolaurate (2OE.O.) 1.0 (e) Ethanol 6.0 (f) Perfume appropriate amount (g) Preservative / antioxidant appropriate amount (h) Purification Water Remaining Total 100.0 The above components (a) to (h) were mixed and uniformly dissolved to prepare a lotion.
【0037】 実施例2 乳液の調製 (重量%) (a) ミツロウ 0.5 (b) ワセリン 2.0 (c) スクワラン 8.0 (d) ソルビタンセスキオレエート 0.8 (e) ポリオキシエチレンオレイルエーテル(2OE.O.) 1.2 (f) オクチルp−メトキシシンナメート 1.0 (g) 1,3−ブチレングリコール 7.0 (h) メチルセルロース 0.2 (i) 水酸化カリウム 0.1 (j) 精製水 残部 (k) 防腐剤・酸化防止剤 適量 (l) L−3−O−エチルアスコルビン酸 1.0 (m) エタノール 7.0 合計 100.0 まず、上記(a)〜(f)成分を加熱溶解し、80℃に保持
した。一方、(g)〜(k)成分を加熱溶解し、80℃に保
ち、上記(a)〜(f)成分に加えて、乳化し、50℃まで
撹拌しながら冷却したのち、これに、50℃で(l)成分
を溶解してなる(m)成分を添加し、40℃まで冷却する
ことにより、乳液を調製した。Example 2 Preparation of emulsion (% by weight) (a) Beeswax 0.5 (b) Vaseline 2.0 (c) Squalane 8.0 (d) Sorbitan sesquioleate 0.8 (e) Polyoxyethylene Oleyl ether (2OE.O.) 1.2 (f) Octyl p-methoxycinnamate 1.0 (g) 1,3-butylene glycol 7.0 (h) Methylcellulose 0.2 (i) Potassium hydroxide 0. 1 (j) Purified water Remainder (k) Preservative / antioxidant appropriate amount (l) L-3-O-ethylascorbic acid 1.0 (m) Ethanol 7.0 Total 100.0 First, the above (a)- The component (f) was dissolved by heating and kept at 80 ° C. On the other hand, the components (g) to (k) are dissolved by heating, kept at 80 ° C., added to the above components (a) to (f), emulsified, cooled to 50 ° C. while stirring, and then cooled to 50 ° C. An emulsion was prepared by adding the component (m) obtained by dissolving the component (l) at a temperature of 40 ° C and cooling to 40 ° C.
【0038】 実施例3 化粧用クレームの調製 (重量%) (a) ミツロウ 2.0 (b) ステアリルアルコール 5.0 (c) ステアリン酸 8.0 (d) スクワラン 10.0 (e) 自己乳化型グリセリルモノステアレート 3.0 (f) ポリオキシエチレンセチルエーテル(2OE.O.) 1.0 (g) 2−ヒドロキシ−4−メトキシベンゾフェノン 1.0 (h) 1,3−ブチレングリコール 5.0 (i) 水酸化カリウム 0.3 (j) 防腐剤・酸化防止剤 適量 (k) L−3−O−エチルアスコルビン酸 1.0 (l) 精製水 残部 合計 100.0 まず、上記(a)〜(f)成分を加熱溶解して、80℃に保
持した。一方、(g)〜(l)成分を加熱溶解して80℃に
保ち、これを上記(a)〜(f)成分に加えて乳化したの
ち、40℃まで撹拌しながら乳化することにより、化粧
用クリームを調製した。Example 3 Preparation of Cosmetic Claims (% by Weight) (a) Beeswax 2.0 (b) Stearyl alcohol 5.0 (c) Stearic acid 8.0 (d) Squalane 10.0 (e) Self-emulsifying Type glyceryl monostearate 3.0 (f) polyoxyethylene cetyl ether (2OE.O.) 1.0 (g) 2-hydroxy-4-methoxybenzophenone 1.0 (h) 1,3-butylene glycol 5. 0 (i) Potassium hydroxide 0.3 (j) Preservative / antioxidant appropriate amount (k) L-3-O-ethylascorbic acid 1.0 (l) Purified water Remainder 100.0 First, the above (a) The components (1) to (f) were dissolved by heating and maintained at 80 ° C. On the other hand, the components (g) to (l) are heated and dissolved and kept at 80 ° C., and then added to the components (a) to (f) to emulsify the mixture. A cream for use was prepared.
【0039】 実施例4 パック剤の調製 (重量%) (a) オクチルp−メトキシシンナメート 0.5 (b) 酢酸ビニル樹脂エマルジョン 15.0 (c) ポリビニルアルコール 10.0 (d) オリーブ油 3.0 (e) L−3−O−エチルアスコルビン酸 1.0 (f) グリセリン 5.0 (g) 酸化チタン 8.0 (h) カオリン 7.0 (i) エタノール 8.0 (j) 香料 適量 (k) 防腐剤・酸化防止剤 適量 (l) 精製水 残部 合計 100.0 まず、上記(a)〜(l)成分を混合し、よく撹拌、分散さ
せ、均質化することにより、パック剤を調製した。Example 4 Preparation of Packing Agent (wt%) (a) Octyl p-methoxycinnamate 0.5 (b) Vinyl acetate resin emulsion 15.0 (c) Polyvinyl alcohol 10.0 (d) Olive oil 0 (e) L-3-O-ethylascorbic acid 1.0 (f) Glycerin 5.0 (g) Titanium oxide 8.0 (h) Kaolin 7.0 (i) Ethanol 8.0 (j) Perfume (k) Preservative / antioxidant appropriate amount (l) purified water remaining total 100.0 First, the above components (a) to (l) are mixed, well stirred, dispersed, and homogenized to obtain a pack agent. Prepared.
【0040】前記実施例1〜4で調製した各化粧料は、
温度40℃において3ケ月間放置しても、着色、沈殿な
どの生成は認められず、配合したL−アスコルビン酸誘
導体も安定であった。Each of the cosmetics prepared in Examples 1 to 4 was
Even when left at a temperature of 40 ° C. for 3 months, generation of coloring, precipitation, and the like was not observed, and the compounded L-ascorbic acid derivative was stable.
【0041】実施例5 乳液の調製 実施例2において、L−3−O−エチルアスコルビン酸
の量を1.0重量%から2.0重量%に変え、かつオク
チルp−メトキシシンナメート1.0重量%を2−エト
キシエチルp−メトキシシンナメート5.0重量%に変
えた以外は、実施例2と同様にして乳液を調製した。Example 5 Preparation of an emulsion In Example 2, the amount of L-3-O-ethylascorbic acid was changed from 1.0% by weight to 2.0% by weight, and octyl p-methoxycinnamate 1.0% An emulsion was prepared in the same manner as in Example 2, except that the weight% was changed to 5.0 weight% of 2-ethoxyethyl p-methoxycinnamate.
【0042】比較例1 乳液の調製 実施例2において、L−3−O−エチルアスコルビン酸
を用いないで、かつオクチルp−メトキシシンナメート
1.0重量%を2−エトキシエチルp−メトキシシンナ
メート5.0重量%に変えた以外は、実施例2と同様に
して乳液を調製した。COMPARATIVE EXAMPLE 1 Preparation of Emulsion In Example 2, 1.0% by weight of octyl p-methoxycinnamate was used without using L-3-O-ethylascorbic acid and 2-ethoxyethyl p-methoxycinnamate An emulsion was prepared in the same manner as in Example 2 except that the amount was changed to 5.0% by weight.
【0043】比較例2 乳液の調製 実施例2において、L−3−O−エチルアスコルビン酸
の量を1.0重量%から2.0重量%に変え、かつオク
チルp−メトキシシンナメートを用いなかったこと以外
は、実施例2と同様にして乳液を調製した。Comparative Example 2 Preparation of an emulsion In Example 2, the amount of L-3-O-ethylascorbic acid was changed from 1.0% by weight to 2.0% by weight, and octyl p-methoxycinnamate was not used. Except for this, an emulsion was prepared in the same manner as in Example 2.
【0044】比較例3 乳液の調製 実施例2において、L−3−O−エチルアスコルビン酸
およびオクチルp−メトキシシンナメートの両方共用い
なかったこと以外は、実施例2と同様にして乳液を調製
した。Comparative Example 3 Preparation of Emulsion An emulsion was prepared in the same manner as in Example 2 except that neither L-3-O-ethylascorbic acid nor octyl p-methoxycinnamate was used. did.
【0045】試験例1 実施例5および比較例1〜3で調製した乳液について、
以下に示すテストを行い、皮膚刺激感と美白効果を評価
した。その結果を表1に示す。Test Example 1 With respect to the emulsions prepared in Example 5 and Comparative Examples 1 to 3,
The following tests were performed to evaluate skin irritation and whitening effect. Table 1 shows the results.
【0046】〈使用テスト〉30〜50才の20名の女
性をパネラーとし、毎日朝と夜の2回、3ケ月間にわた
り洗顔後に試験乳液を顔面に塗布し、下記の基準に従っ
て、皮膚刺激感および美白効果を評価した。 (1) 皮膚刺激感評価基準 ・有効 :刺激感なし。 ・やや有効:やや弱いが刺激を感じる。 ・無効 :刺激感を感じる。 (2) 美白効果評価基準 ・有効 :シミ、ソバカスが目立たなくなった。 ・やや有効:シミ、ソバカスがあまり目立たなくなっ
た。 ・無効 :変わらない。<Usage Test> Twenty women aged 30 to 50 were used as panelists, and the test emulsion was applied to the face twice a day for three months, twice a day in the morning and night, and the skin was irritated according to the following criteria. And the whitening effect was evaluated. (1) Evaluation criteria for skin irritation ・ Effective: No irritation.・ Slightly effective: Slightly weak but stimulating.・ Invalid: Irritation is felt. (2) Whitening effect evaluation criteria-Effective: spots and freckles became less noticeable.・ Slightly effective: spots and freckles are less noticeable. -Invalid: No change.
【0047】試験例2 実施例5および比較例1〜3で調製した乳液について、
以下に示すテストを行い、皮膚色明度回復性を評価し
た。その結果を表1に示す。Test Example 2 For the emulsions prepared in Example 5 and Comparative Examples 1 to 3,
The following test was performed to evaluate skin color lightness recovery. Table 1 shows the results.
【0048】〈皮膚色明度回復テスト〉30〜50才の
10名の女性をパネラーとし、上腕部皮膚に、UV−B
領域の紫外線(波長320〜290nm)を最小紅斑量
の2倍量照射した。その後、照射部位にそれぞれ試験乳
液を1日に2回ずつ塗布し、2ケ月後の皮膚色をミノル
タ製彩色色差計CR−300にてL値を測定した。明度
を示すL値を測定することにより、日焼けからの回復度
を求めた。なお、それぞれの値は、比較例3のL値との
差を示している。<Skin color lightness recovery test> Ten women aged 30 to 50 years were panelists, and UV-B was applied to the upper arm skin.
The region was irradiated with ultraviolet rays (wavelength 320 to 290 nm) twice as much as the minimum erythema dose. Thereafter, the test emulsion was applied twice a day to each of the irradiated sites, and the skin color after two months was measured for the L value with a Minolta colorimeter CR-300. The degree of recovery from sunburn was determined by measuring the L value indicating the lightness. In addition, each value has shown the difference with the L value of the comparative example 3.
【0049】[0049]
【表1】 [Table 1]
【0050】表1から明らかなように、実施例5の乳液
は、皮膚の刺激感緩和に対し、有効であるとともに、美
白効果についても高い効果を示した。また、実施例5の
乳液は、比較例3の乳液と比較してL値が約3.5高
く、目視においても皮膚色が白くなっていることが明ら
かであった。As is evident from Table 1, the emulsion of Example 5 was effective in alleviating the irritating feeling of the skin and also exhibited a high whitening effect. Moreover, the L value of the emulsion of Example 5 was about 3.5 higher than that of Comparative Example 3, and it was clear that the skin color was white even visually.
【0051】[0051]
【発明の効果】本発明の化粧料は、紫外線吸収剤を配合
した場合の皮膚刺激感の緩和に優れており、また、日焼
けによる黒色化、シミ、ソバカスの防止、改善など幅広
く適用することができる。また、上記効果に加えて、美
白効果にも優れる上、保存安定性および皮膚安全性が高
く、安心して使用することができる。Industrial Applicability The cosmetic of the present invention is excellent in alleviating skin irritation when an ultraviolet absorber is incorporated, and can be widely applied for preventing and improving blackening due to sunburn, spots and freckles. it can. Further, in addition to the above-mentioned effects, the whitening effect is excellent, and the storage stability and skin safety are high, so that it can be used with confidence.
Claims (4)
表されるL−アスコルビン酸誘導体と、(B)紫外線吸
収剤を含有することを特徴とする化粧料。(A) General formula (I) (In the formula, R is an alkyl group having 1 to 22 carbon atoms.) A cosmetic comprising an L-ascorbic acid derivative represented by the formula (B) and an ultraviolet absorber (B).
が、一般式(I)におけるRがエチル基のL−3−O−
エチルアスコルビン酸である請求項1に記載の化粧料。2. The L-ascorbic acid derivative of the component (A) is a compound of the formula (I) wherein R is an ethyl-3-L-O-.
The cosmetic according to claim 1, which is ethyl ascorbic acid.
−p−メトキシシンナメート、2−ヒドロキシ−4−メ
トキシベンゾフェノンおよび4−メトキシ−4′−te
rt−ブチルジベンゾイルメタンの中から選ばれる少な
くとも1種である請求項1または2に記載の化粧料。3. The ultraviolet absorber of the component (B) is octyl-p-methoxycinnamate, 2-hydroxy-4-methoxybenzophenone and 4-methoxy-4'-te.
The cosmetic according to claim 1 or 2, wherein the cosmetic is at least one selected from rt-butyldibenzoylmethane.
が、重量比で1:50〜50:1の範囲にある請求項
1、2または3に記載の化粧料。4. The cosmetic according to claim 1, wherein the content ratio of the component (A) to the component (B) is in the range of 1:50 to 50: 1 by weight.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10000192A JPH11199425A (en) | 1998-01-05 | 1998-01-05 | Cosmetic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10000192A JPH11199425A (en) | 1998-01-05 | 1998-01-05 | Cosmetic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH11199425A true JPH11199425A (en) | 1999-07-27 |
Family
ID=11467143
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10000192A Pending JPH11199425A (en) | 1998-01-05 | 1998-01-05 | Cosmetic |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH11199425A (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002284623A (en) * | 2001-03-23 | 2002-10-03 | Nippon Hypox Lab Inc | Cosmetics |
| JP2002284666A (en) * | 2001-03-23 | 2002-10-03 | Nippon Hypox Lab Inc | Cosmetics |
| JP2002284626A (en) * | 2001-03-23 | 2002-10-03 | Nippon Hypox Lab Inc | External skin preparation |
| KR20020093627A (en) * | 2001-06-08 | 2002-12-16 | 가부시키가이샤 시세이도 | Method of preventing darkening of skin or inhibiting melanization of melanin monomer and polymerization inhibitor of biological dihydroxyindole compound |
| JP2005002323A (en) * | 2003-05-16 | 2005-01-06 | Umeda Jimusho:Kk | Natural water-soluble ultraviolet light absorber composition, cosmetic given by using the same, and stabilizer for vitamin c |
| JP2008530288A (en) * | 2005-02-09 | 2008-08-07 | エシロール アンテルナシオナル (コンパニー ジェネラレ ドプテイク) | Stabilized UV absorber |
| JP2013227264A (en) * | 2012-04-27 | 2013-11-07 | Mikimoto Pharmaceut Co Ltd | External preparation for skin |
| WO2015190505A1 (en) * | 2014-06-10 | 2015-12-17 | 味の素株式会社 | Cosmetic composition containing 3-o-alkyl-l-ascorbic acid or salt thereof |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6178715A (en) * | 1984-09-26 | 1986-04-22 | Shiseido Co Ltd | Cosmetic |
| JPH03505089A (en) * | 1988-06-18 | 1991-11-07 | ヘンケル・コマンディットゲゼルシャフト・アウフ・アクチェン | Cosmetic and medicinal topical preparations |
| JPH0632721A (en) * | 1992-07-13 | 1994-02-08 | Shiseido Co Ltd | External preparation for skin |
| JPH0782134A (en) * | 1993-09-17 | 1995-03-28 | Nippon High Potsukusu:Kk | Cosmetic for preventing damage by ultraviolet ray |
| JPH07324027A (en) * | 1994-05-30 | 1995-12-12 | Kanebo Ltd | Skin-beautifying cosmetic |
| JPH08198738A (en) * | 1995-01-31 | 1996-08-06 | Kansai Kouso Kk | Liquid cosmetic composition for skin |
| JPH09235216A (en) * | 1996-02-29 | 1997-09-09 | Shiseido Co Ltd | Ultraviolet-absorbing skin cosmetic |
| JPH09263513A (en) * | 1996-03-29 | 1997-10-07 | Shiseido Co Ltd | Preparation for external use for skin |
-
1998
- 1998-01-05 JP JP10000192A patent/JPH11199425A/en active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6178715A (en) * | 1984-09-26 | 1986-04-22 | Shiseido Co Ltd | Cosmetic |
| JPH03505089A (en) * | 1988-06-18 | 1991-11-07 | ヘンケル・コマンディットゲゼルシャフト・アウフ・アクチェン | Cosmetic and medicinal topical preparations |
| JPH0632721A (en) * | 1992-07-13 | 1994-02-08 | Shiseido Co Ltd | External preparation for skin |
| JPH0782134A (en) * | 1993-09-17 | 1995-03-28 | Nippon High Potsukusu:Kk | Cosmetic for preventing damage by ultraviolet ray |
| JPH07324027A (en) * | 1994-05-30 | 1995-12-12 | Kanebo Ltd | Skin-beautifying cosmetic |
| JPH08198738A (en) * | 1995-01-31 | 1996-08-06 | Kansai Kouso Kk | Liquid cosmetic composition for skin |
| JPH09235216A (en) * | 1996-02-29 | 1997-09-09 | Shiseido Co Ltd | Ultraviolet-absorbing skin cosmetic |
| JPH09263513A (en) * | 1996-03-29 | 1997-10-07 | Shiseido Co Ltd | Preparation for external use for skin |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002284623A (en) * | 2001-03-23 | 2002-10-03 | Nippon Hypox Lab Inc | Cosmetics |
| JP2002284666A (en) * | 2001-03-23 | 2002-10-03 | Nippon Hypox Lab Inc | Cosmetics |
| JP2002284626A (en) * | 2001-03-23 | 2002-10-03 | Nippon Hypox Lab Inc | External skin preparation |
| KR20020093627A (en) * | 2001-06-08 | 2002-12-16 | 가부시키가이샤 시세이도 | Method of preventing darkening of skin or inhibiting melanization of melanin monomer and polymerization inhibitor of biological dihydroxyindole compound |
| US6861050B2 (en) | 2001-06-08 | 2005-03-01 | Shiseido Company, Ltd. | Method of preventing darkening of skin or inhibiting melanization of melenin monomer and polymerization inhibitor of biological dihydroxyindole compound |
| JP2005002323A (en) * | 2003-05-16 | 2005-01-06 | Umeda Jimusho:Kk | Natural water-soluble ultraviolet light absorber composition, cosmetic given by using the same, and stabilizer for vitamin c |
| JP2008530288A (en) * | 2005-02-09 | 2008-08-07 | エシロール アンテルナシオナル (コンパニー ジェネラレ ドプテイク) | Stabilized UV absorber |
| JP2013227264A (en) * | 2012-04-27 | 2013-11-07 | Mikimoto Pharmaceut Co Ltd | External preparation for skin |
| WO2015190505A1 (en) * | 2014-06-10 | 2015-12-17 | 味の素株式会社 | Cosmetic composition containing 3-o-alkyl-l-ascorbic acid or salt thereof |
| CN106659662A (en) * | 2014-06-10 | 2017-05-10 | 味之素株式会社 | Cosmetic composition containing 3-o-alkyl-l-ascorbic acid or salt thereof |
| US10322078B2 (en) | 2014-06-10 | 2019-06-18 | Ajinomoto Co., Inc. | Cosmetic composition containing 3-O-alkyl-L-ascorbic acid or salt thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100594548B1 (en) | Cosmetic composition | |
| KR100844036B1 (en) | Cosmetics | |
| JPWO1997002803A1 (en) | topical skin preparations | |
| KR102463133B1 (en) | Cosmetic Composition Containing High-Content of Urea | |
| JPH11199426A (en) | Cosmetic | |
| JP2004175750A (en) | Dermopathy inhibitor and dermopathy improving agent, and skin care preparation for external use containing them | |
| JPH11269034A (en) | Skin prepafation for external use for improving acne | |
| JP4138679B2 (en) | Irritation relief agent | |
| CN109310585B (en) | Skin topical agent for improving wrinkles | |
| JP2003252718A (en) | In vivo dihydroxyindole compound polymerization inhibitor | |
| JP4053966B2 (en) | Skin external preparation and skin irritation relieving agent | |
| JP7507604B2 (en) | Cosmetics | |
| JPH07196443A (en) | External agent for skin | |
| JP2008007444A (en) | A novel cinnamic acid derivative, its use as an ultraviolet absorber, and an ultraviolet-absorbing composition and an external preparation for skin containing the same. | |
| JP5235423B2 (en) | Skin external composition | |
| KR102259110B1 (en) | anti-wrinkle | |
| JP2886222B2 (en) | External preparation for anti-pigmentation | |
| JP5117758B2 (en) | UV absorber and UV-absorbing skin external preparation composition containing the same | |
| JPS6239517A (en) | Cosmetic | |
| JP2002284666A (en) | Cosmetics | |
| JP2000281555A (en) | External preparation for skin | |
| JP2000063256A (en) | Preparation for external use for skin | |
| JPH10259142A (en) | Cosmetic | |
| JP4671222B2 (en) | Skin preparation | |
| JP2017119654A (en) | Skin cosmetic and method for producing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20031030 |